Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

442 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Price of Crossing the Border for Medications.
Fralick M, Avorn J, Kesselheim AS. Fralick M, et al. N Engl J Med. 2017 Jul 27;377(4):311-313. doi: 10.1056/NEJMp1704489. N Engl J Med. 2017. PMID: 28745989 No abstract available.
University-based science and biotechnology products: defining the boundaries of intellectual property.
Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2005 Feb 16;293(7):850-4. doi: 10.1001/jama.293.7.850. JAMA. 2005. PMID: 15713775
The pharmaceutical and biotechnology industries have long relied on patenting as the primary means of allocating ownership and control over new discoveries. ...
The pharmaceutical and biotechnology industries have long relied on patenting as the primary means of allocating ownership and contro …
Overbilling vs. downcoding--the battle between physicians and insurers.
Kesselheim AS, Brennan TA. Kesselheim AS, et al. N Engl J Med. 2005 Mar 3;352(9):855-7. doi: 10.1056/NEJMp058011. N Engl J Med. 2005. PMID: 15745973 No abstract available.
Biomedical patents and the public's health: is there a role for eminent domain?
Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2006 Jan 25;295(4):434-7. doi: 10.1001/jama.295.4.434. JAMA. 2006. PMID: 16434634 No abstract available.
Medical-process patents--monopolizing the delivery of health care.
Kesselheim AS, Mello MM. Kesselheim AS, et al. N Engl J Med. 2006 Nov 9;355(19):2036-41. doi: 10.1056/NEJMhpr063626. N Engl J Med. 2006. PMID: 17093256 No abstract available.
Market-based licensing for HPV vaccines in developing countries.
Outterson K, Kesselheim AS. Outterson K, et al. Health Aff (Millwood). 2008 Jan-Feb;27(1):130-9. doi: 10.1377/hlthaff.27.1.130. Health Aff (Millwood). 2008. PMID: 18180488
Scientific and legal viability of follow-on protein drugs.
Dudzinski DM, Kesselheim AS. Dudzinski DM, et al. N Engl J Med. 2008 Feb 21;358(8):843-9. doi: 10.1056/NEJMhle0706973. N Engl J Med. 2008. PMID: 18287608 No abstract available.
The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients.
Kesselheim AS, Choudhry NK. Kesselheim AS, et al. Ann Intern Med. 2008 Apr 15;148(8):614-9. doi: 10.7326/0003-4819-148-8-200804150-00006. Ann Intern Med. 2008. PMID: 18413623
As patient use of foreign-bought drugs has increased, federal legislators have continued to debate the full legalization of importation. Three factors help guide whether U.S. patients and policymakers can rely on other countries as sources of imported prescription d
As patient use of foreign-bought drugs has increased, federal legislators have continued to debate the full legalization of importati
442 results
Jump to page
Feedback